Object: To investigate and report our experience with extra-operative, intracranial EEG monitoring for evaluation of epilepsy surgery among elderly (≥60 years) patients.
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Introduction:
Resective epilepsy surgery (RES) in patients with drug resistant epilepsy can often be planned based on information from noninvasive diagnostic techniques. However, a subgroup of patients may require additional information in form of extraoperative, intracranial electroencephalography (eiEEG) monitoring (Jaykar et al., 2016) . Recent systematic review and meta-analysis of two most commonly used eiEEG modalities -subdural grids (SDG) and stereo-electroencephalopgraphy (SEEG), found them to be generally safe techniques with low surgical complication rates (Arya et al., 2013; Mullin et al., 2016 ) They report the mean age of patients undergoing eiEEG ranging from 24 (Mullin et al., 2016) to 37 years (Arya et al., 2013) , which suggests that eiEEG is most frequently used in young adults. However, the incidence of unprovoked seizures and epilepsy starts to rapidly rise after the age of 55 years (Hauser et al., 1993) and may have an almost fivefold increase after the age of 65 years (Sillanpaa et al., 2016) .
Today's elderly population is healthier, with a longer life expectancy than ever before (Crimmins, 2004) and is expected to double over the next 30 years (Ortman et al., 2014) in the developed world. Our recent report on the largest series of 51 elderly patients (≥60 years) undergoing RES showed that 80% of them can achieve Engel I outcome, which was comparable to young adults (25 -45 years old) (Punia et al., 2018) . This evidence of efficacy and safety of RES in elderly (Punia et al., 2018) in combination with population trends mean that more elderly patients may be candidates for eiEEG. years. However, to our knowledge, prior studies have not specifically analyzed the use of eiEEG in this population. Therefore, the aim of our study is to report, for the first time in literature, a single center experience with eiEEG in the elderly patients.
Methods:
After IRB approval, we searched our prospectively maintained epilepsy surgery data base from 01/01/2000 to 12/31/2016 to find patients who underwent eiEEG at the age of 60 years or older. Electronic medical records were reviewed to extract clinical and surgery related information. The MRI findings were classified into negative (non-
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A C C E P T E D M A N U S C R I P T 4 lesional), unilateral or bilateral (lesions present in both hemispheres). The indication for undergoing eiEEG was analyzed based on the review of surgical patient management conference note in the clinical chart and was classified as:
"Lateralization" -patients with bilateral lesion (e.g. hippocampal sclerosis); "Localization" -for better defining epileptogenic zone and resection strategy; "functional mapping" -for localization of eloquent regions. Patients who underwent RES after eiEEG and had at least 1 year of clinical follow-up were assessed for seizure outcome classified according to Engel's criteria. Categorical variables were described using frequencies and percentages (rounded to nearest integer), while continuous variables were described using mean and standard deviations or medians and quartiles (first and third), as appropriate. Categorical and continuous variables were compared using Pearson chisquare and Student's t-test, respectively.
Results:
A total of 21 elderly patients, including 13 (62%) women, underwent eiEEG in our center during the study period. The Table 1 -including one with SDG combination approach). Mean number of days of eiEEG monitoring was 8.5 ± 4.2 days (mean SDG duration = 9 ± 3 days; mean SEEG duration = 8 ± 4.4 days; p = 0.59). Median number of contacts in SDG were 106 (56 -136) and 130 (16 -220) in SEEG (including depth electrodes used in combination with SDG). The median number of depth electrodes used in patients undergoing SEEG were 12 (9 -14) . Maximum number of depth electrodes used were 18 ( 
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A C C E P T E D M A N U S C R I P T 5 eiEEG related mortality: This patient was a 62 years old man with no other significant medical history. He suffered from a post-traumatic brain injury epilepsy since the age of 10 years. He was taking 3 anti-epileptic drugs (Lacosamide, Zonisamide and Pheynytoin) along with calcium and multivitamin supplements at time of eiEEG implantation. He underwent bilateral implantation of a total of 14 electrodes using neuro-navigation system and a robotic arm. Postoperatively, he was noted to be unresponsive and with left, non-reactive, dilated pupil. He received immediate mannitol and a stat CT scan showed large parietal intracranial hemorrhage, with a 17 mm midline shift. Urgent craniotomy and evacuation was performed. Due to the poor neurological status after surgery, the family requested not to pursue aggressive medical treatment, and the patient died after 48 hours of eiEEG implantation.
Sixteen (76%) patients underwent RES after eiEEG, of which temporal lobectomy was the most common surgery [44% (7 out of 16) patients] ( Table 1) . Of the five patients who did not undergo RES, four were not found to be ideal surgical candidates (Table 1 - We did not compare our study population to a young adult cohort because all the case series published so far, and the systematic reviews/meta-analysis by corollary, are derived from younger patients ( neuroimaging at times of minor changes in mental status or neurological examination in the elderly may be critical for preventing major complication. Additional factors that may increase the risk of hemorrhage from intracranial electrode implantation in the elderly include their higher likelihood of use of anti-platelet agents or possible, undiagnosed amyloid angiopathy. Such factors must be considered before eiEEG implantation in this age group. However, of note, our patient who expired post-eiEEG implantation was not on antiplatelet agents. There was no imaging evidence or post-mortem pathology report available to suggest amyloid angiopathy.
Conclusion
Our study shows that eiEEG can be offered to a well selected elderly patient population. There relatively recent increase in its utilization for pre-RES evaluation among the elderly may be secondary to the e advent of low-morbidity technique of SEEG in North America. Although the experience with eiEEG in elderly is limited to conclude its safety and the one death in our cohort serves a word of caution required during implantation in this patient population, the outcomes are similar to young adults. Three quarter of the patients evaluated with intracranial electrodes underwent RES and the majority of them achieved seizure freedom. Therefore, our experience, suggests that an elderly patient should not be denied RES due to the want of an eiEEG evaluation. Given the demographical trends of a rapidly aging population, future studies geared towards the identification of elderly patients with the highest benefit to risk ratio for undergoing eiEEG and the subsequent RES are required.  First report on extra-operative, intracranial EEG (eiEEG) monitoring use in the elderly.
 Twenty-one elderly patients underwent eiEEG at the mean age of 63.8 ± 2.7 years.
 Sixteen (76%) underwent surgery after eiEEG and 11 (69%) achieved Engel class I outcome.
 Utilization of eiEEG increased after the introduction of stereo EEG (SEEG) at our center. Figure 1 
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